VAERS Explorer
Back to explore

Report #2844130

Received Jun 5, 2025

Life-threateningER / ED visit
A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
61 yrs
State
ME
Recovered
Not recovered
Vaccinated
Jun 11, 2024
Onset
Jun 14, 2024
Days to onset
3
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
RSVRSV (ABRYSVO)PFIZER\WYETH1HMO168—

Symptoms (2)

DyspnoeaGait inability

Symptom narrative

difficulty breathing/more trouble breathing; could not walk; This is a spontaneous report received from a Consumer or other non HCP. A 61-year-old male patient received rsv vaccine prot.subunit pref 2v (ABRYSVO), on 11Jun2024 at 15:00 as dose 1, single (Lot number: HMO168) at the age of 61 years for immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: DOVATO. The following information was reported: GAIT INABILITY (life threatening) with onset 14Jun2024 at 07:00, outcome "recovering", described as "could not walk"; DYSPNOEA (life threatening) with onset 14Jun2024 at 07:00, outcome "recovering", described as "difficulty breathing/more trouble breathing". The events "difficulty breathing/more trouble breathing" and "could not walk" required emergency room visit. Therapeutic measures were not taken as a result of dyspnoea, gait inability.

Other medications

DOVATO